Already a member? Sign in
Azathioprine is an immunosuppressant agent used to manage active rheumatoid arthritis and as an adjunctive therapy for the prevention of rejection of kidney transplants.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Prevent organ rejection | 108 | 9 |
|
|
|
||
| Neuromyelitis Optica | 46 | 12 |
|
|
|
|
|
| MS (Multiple Sclerosis) | 40 | 12 |
|
|
|
|
|
| Systemic Lupus Erythematosus | 32 | 10 |
|
|
|
|
|
| Transplant rejection prevention | 30 | 11 |
|
|
|||
| Crohn's Disease | 14 | 6 |
|
|
|
See all 339 patients currently taking Azathioprine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Azathioprine
| Vomiting | 8 | |
|---|---|---|
| Hair loss | 8 | |
| Stomach upset | 6 | |
| Nausea | 5 | |
| Hospitalization | 4 | |
| Flat warts | 4 | |
| See all 56 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Azathioprine. See all 22 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 44 | ||
| Side effects too severe | 34 | ||
| Did not seem to work | 23 | ||
| Other | 22 | ||
| Course of treatment ended | 14 | ||
| Personal research | 4 | ||
| Change in health plan coverage | 3 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Azathioprine
Always |
76 | 87% |
|
|---|---|---|---|
Usually |
7 | 8% |
|
Sometimes |
1 | 1% |
|
Never |
3 | 3% |
|
Burden
Difficulty being on treatment
Burden of Azathioprine
Very |
2 | 2% |
|
|---|---|---|---|
Somewhat |
4 | 5% |
|
A little |
15 | 17% |
|
Not at all |
66 | 76% |
|
Cost
Paid out of pocket
Cost of Azathioprine
$200+ |
2 | 3% |
|
|---|---|---|---|
$100-199 |
2 | 3% |
|
$50-99 |
3 | 5% |
|
$25-49 |
1 | 2% |
|
< $25 |
51 | 86% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 25, 2012.